Cardiovascular Safety Issues: QT prolongation and Valvulopathy

First Page		Document Content
Drug discovery Pharmaceutical industry Pharmaceutical sciences Medicine Syndromes QT interval Long QT syndrome Torsades de pointes Clinical trial Cardiac dysrhythmia Health Pharmacology		Cardiovascular Safety Issues: QT prolongation and Valvulopathy Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 275,63 KB Share Document on Facebook

	Challenges of Long QT Syndrome in Pregnancy Case Presentation Erika L. Jones, M.D. University of Southern California Los Angeles, California USA DocID: 1v3yR - View Document
	B’SYS GmbH HEK-Tet hERG Cell Line Specification Sheet © B’SYS GmbH DocID: 1rqng - View Document
	B’SYS GmbH CHO KVLQT1/minK Cell Line Specification Sheet © B’SYS GmbH DocID: 1rn53 - View Document
	B’SYS GmbH HEK-293 CaV1.2 Cells Specification Sheet © B’SYS GmbH DocID: 1qU1t - View Document
	F B’SYS GmbH CHO-Tet hERG Cell Line Specification Sheet DocID: 1paVz - View Document